Fundraising Fox

Outcomes4Me

Cambridge, US · Founded 2017 · Delaware corporation · 34 employees on LinkedIn · 4 known investors

Outcomes4Me is an AI-driven patient platform that integrates with NCCN clinical oncology guidelines to provide personalized cancer care guidance, treatment options, clinical trial recommendations, and genetic testing information. The platform serves cancer patients directly by offering decision support tools and health data management to improve treatment access and outcomes.

AI & Machine LearningDigital HealthHealthtech

Founders & leadership

Outcomes4Me was founded in 2017 by Maya R. Said and Osama Rahma.

MRMaya R. Said
Maya R. SaidFounder and CEO
OR
Osama RahmaFounder

Board

AJAndrea Jackson
Andrea JacksoninBoard directorPartner at Northpond Ventures
DF
David FleshmanBoard director
DA
David AucklandBoard director

Investors · 4

Asset Management CompanyMenlo Park · $500K – $2M
HealthX VenturesMadison
Sierra VenturesSan Mateo · $10M
Northpond VenturesreportedBethesda · $100K – $5M

Funding

SEC filings, press & company announcements

$37.5M disclosed across 3 rounds · 2020–2025

▶$12MraisedApr 2021 · 7 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrea JacksonDirector
  • David AucklandDirector
  • Maya SaidExecutive Officer, Director
  • David FleshmanDirector
Offering amount
$12M
Amount sold
$12M
First sale
Apr 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.5MraisedJan 2020 · 6 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • David AucklandDirector
  • David FleshmanDirector
  • Maya SaidExecutive Officer, Director
Offering amount
$4.5M
Amount sold
$4.5M
First sale
Jan 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap
Cancerresearchuk5727 shared keywordsCancer Research UK funds research across discovery, detection, prevention and treatment of cancer to improve patient outcomes and extend survival. It operates as a research funder and scientific organization serving academic and clinical researchers.
American Cancer Society (ACS)5630 shared keywordsThe American Cancer Society is a nonprofit cancer-fighting organization that combats cancer through advocacy, research, and patient support. It provides information, guidance, caregiver resources, screening guidance, and clinical trial navigation for cancer patients, families, and caregivers, and funds cancer research.
MD Anderson Cancer Center4302 shared keywordsUT MD Anderson is a cancer hospital providing cancer treatment, prevention, clinical care, and research, including new therapies and clinical trials for cancer patients. It is ranked among the top hospitals in the U.S. for cancer care.

Companies competing with Outcomes4Me for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2020$399.7K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Outcomes4Me Raises $21M in Fundingfinsmes.com · May 2025Outcomes4Me Secures $21M in Funding to Accelerate AI-Driven Innovation and Drive Global Expansion to Transform Cancer Care - Outcomes4Meoutcomes4me.com · May 2025Outcomes4Me Secures $21M in Funding to Accelerate AI-Driven Innovation and Drive Global Expansion to Transform Cancer Careprnewswire.com · May 2025Outcomes4Me Raises $12 Million in Oversubscribed Series A to Fuel Expansion of AI-Powered Cancer Patient Empowerment Platform - Outcomes4Meoutcomes4me.com · Apr 2021Outcomes4Me Raises $12 Million in Oversubscribed Series A to Fuel Expansion of AI-Powered Cancer Patient Empowerment Platformprnewswire.com · Apr 2021Outcomes4Me Raises $4.7 Million to Help Patients Navigate Cancer Care Using AI - Outcomes4Meoutcomes4me.com · Nov 2020

Frequently asked questions

What does Outcomes4Me do?
Outcomes4Me is an AI-driven patient platform that integrates with NCCN clinical oncology guidelines to provide personalized cancer care guidance, treatment options, clinical trial recommendations, and genetic testing information. The platform serves cancer patients directly by offering decision support tools and health data management to improve treatment access and outcomes.
Who founded Outcomes4Me?
Outcomes4Me was founded by Maya R. Said, Osama Rahma in 2017.
Who are Outcomes4Me's investors?
Outcomes4Me's investors include Asset Management Company, HealthX Ventures, Sierra Ventures, Northpond Ventures.
How much funding has Outcomes4Me raised?
Outcomes4Me has disclosed $37.5M raised across 3 rounds.
Where is Outcomes4Me headquartered?
Outcomes4Me is headquartered in Cambridge, US.